Sponsor Pipeline

Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-21 NCT07717268 Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for… Phase 2 Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05781217 Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate… Prostate Cancer Recruiting
Phase 2
NCT07717268 Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for… Prostatic Neoplasms, Castration-Resistant Recruiting
Not specified
NCT05209243 START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC Prostate Cancer Recruiting
Disease Areas
Prostate Cancer (2)
Get alerts when Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free